When does patent/market exclusivity for roflumilast cream expire?
The information needed to state a specific “target exclusivity expiry” date for roflumilast cream (the “0.3%” and “0.15%” strengths are commonly referenced in marketing materials) is not provided in the input you shared. Without the relevant patent and regulatory documents (patent numbers, jurisdictions, and the exclusivity type: patent term vs. data exclusivity vs. marketing authorization exclusivity), I can’t give an accurate expiry date.
What does “exclusivity expiry” usually include (and which date matters)?
“Exclusivity expiry” can mean different legal concepts:
- Patent term expiry (the last day a valid patent blocks competitors).
- Regulatory data exclusivity (a period during which regulators may not rely on another company’s proprietary clinical data).
- Market/marketing authorization exclusivity (a period linked to approval/authorization protection).
Each can expire on different dates, and the “target” date depends on which one you mean and which country/region you’re tracking.
Which details do you need to get the exact expiry date?
If you provide the following, I can pinpoint the relevant expiry target precisely:
- Jurisdiction (e.g., US, EU, UK, or specific countries)
- Product details (which exact strength/formulation: the “0.3%” vs “0.15%” reference, and the dosage form)
- The patent numbers you’re tracking (or the company/app you’re following)
- Whether you mean patent expiry or regulatory exclusivity (data/market exclusivity)
Quick clarification to move forward
When you say “target exclusivity expiry,” do you mean:
1) patent term expiry, or
2) regulatory exclusivity (data/market protection), and
for which market/country?